R. Alex Hsi, MD
Being a physician gives me the opportunity to contribute to society on both an individual level, through clinical practice, and a community level, by participating in research and education. One of the benefits of radiation oncology as a specialty is that it allows me to treat people from a variety of social, economic and racial backgrounds who are dealing with a broad spectrum of diseases. It’s a field where science, technology and patient care intersect in a way that is both very challenging and very rewarding.
Advances in technology and science have allowed us to make great strides in the treatment of cancer. Yet practicing the art of medicine — listening intently to patients and understanding their needs — is vital to achieving optimal outcomes and providing quality care. Each person comes to my office with varying levels of knowledge and concerns about radiation therapy. I enjoy walking you through the different treatment options, step by step, so that you can choose the one that’s right for you and hopefully go home with a little peace of mind.
Specialties and clinical expertise: Radiation Oncology
I am a radiation oncologist with more than 20 years of experience in cancer care. I specialize in the treatment of prostate and bladder cancers and primarily work with patients at SCCA Peninsula, a radiation oncology clinic located in Poulsbo, Washington. My background includes serving as the section chief for radiation oncology at Virginia Mason Medical Center and co-founding the Peninsula Cancer Center (now known as SCCA Peninsula). My research is focused on improving the treatment of prostate cancer. My colleagues and I led the first U.S. clinical trials of both stereotactic body radiation therapy — a type of focused external beam radiation therapy that precisely targets cancer cells — and SpaceOAR hydrogel, which reduces radiation side effects to areas surrounding the prostate. Currently, I am a primary investigator for a clinical trial on focal brachytherapy for recurrent prostate cancer. This form of therapy involves placing radioactive implants directly at the tumor site.
We make promising new treatments available to you through studies called clinical trials led by SCCA doctors. Many of these trials at SCCA have led to FDA-approved treatments and have improved standards of care globally. Together, you and your doctor can decide if a study is right for you.
Many of our SCCA physicians conduct ongoing research to improve standards of patient care. Their work is evaluated by other physicians and selected for publication to the United States National Library of Medicine, the largest medical library in the world. See scientific papers this SCCA provider has written.
Your care team
SCCA accepts most national private health insurance plans as well as Medicare. We also accept Medicaid for people from Washington, Alaska, Montana and Idaho. We are working to ensure that everyone, no matter what their financial situation, has access to the care they need.